| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 826.34B | 825.59B | 836.28B | 773.96B | 642.02B |
| Gross Profit | 158.68B | 148.24B | 152.13B | 133.33B | 112.93B |
| EBITDA | 71.53B | 65.55B | 70.17B | 59.41B | 46.15B |
| Net Income | 12.87B | -23.80B | 10.57B | 10.37B | 7.34B |
Balance Sheet | |||||
| Total Assets | 878.68B | 856.42B | 910.25B | 869.83B | 855.48B |
| Cash, Cash Equivalents and Short-Term Investments | 132.63B | 131.52B | 130.03B | 111.66B | 128.64B |
| Total Debt | 319.17B | 370.49B | 374.48B | 388.01B | 403.55B |
| Total Liabilities | 567.28B | 607.72B | 629.43B | 632.40B | 639.06B |
| Stockholders Equity | 296.90B | 232.89B | 264.33B | 220.66B | 197.85B |
Cash Flow | |||||
| Free Cash Flow | 28.06B | 22.09B | 40.38B | 14.51B | -7.38B |
| Operating Cash Flow | 57.18B | 45.62B | 65.10B | 34.22B | 8.96B |
| Investing Cash Flow | -26.28B | -25.96B | -24.97B | -13.86B | 2.51B |
| Financing Cash Flow | -35.32B | -18.71B | -30.21B | -33.26B | -41.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥1.01T | 25.08 | 9.10% | 1.63% | 9.80% | 13.15% | |
74 Outperform | ¥317.15B | 16.78 | 7.86% | 2.55% | 5.68% | 41.20% | |
71 Outperform | ¥161.92B | 39.12 | ― | 2.82% | 15.90% | 313.65% | |
66 Neutral | ¥86.56B | 7.19 | 6.66% | 3.36% | 1.87% | 86.87% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥137.95B | 25.57 | 2.64% | 2.30% | 0.90% | 15.74% | |
60 Neutral | ¥269.37B | 19.56 | -4.83% | 3.08% | 0.09% | ― |